Related references
Note: Only part of the references are listed.Fisetin inhibits various attributes of angiogenesis in vitro and in vivo-implications for angioprevention
Tariq A. Bhat et al.
CARCINOGENESIS (2012)
VapB as a regulator of osteoclastogenesis via modulation of PLCγ2-Ca2+-NFAT signaling
Sik-Won Choi et al.
FEBS LETTERS (2012)
Fisetin prevents fluoride- and dexamethasone-induced oxidative damage in osteoblast and hippocampal cells
Iwona Inkielewicz-Stepniak et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment
Atsushi Arai et al.
JOURNAL OF CELL SCIENCE (2012)
Securin depletion sensitizes human colon cancer cells to fisetin-induced apoptosis
Sz-Hsien Yu et al.
CANCER LETTERS (2011)
Anti-resorptive saurolactam exhibits in vitro anti-inflammatory activity via ERK-NF-κB signaling pathway
Su-Ui Lee et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models
Jae-Dong Lee et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Saurolactam Inhibits Osteoclast Differentiation and Stimulates Apoptosis of Mature Osteoclasts
Myung Hee Kim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Inhibitory Effect of (-)-saucerneol on Osteoclast Differentiation and Bone Pit Formation
Soon Nam Kim et al.
PHYTOTHERAPY RESEARCH (2009)
Licochalcone A inhibits the formation and bone resorptive activity of osteoclasts
Soon Nam Kim et al.
CELL BIOLOGY INTERNATIONAL (2008)
Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis
Myung Hee Kim et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
The Tec family tyrosine kinase Btk regulates RANKL-induced osteoclast maturation
Seoung Hoon Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption
Cheol Kyu Park et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation
Sudarshana M. Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The molecular understanding of osteoclast differentiation
Masataka Asagiri et al.
BONE (2007)
p38 MAPK as a potential therapeutic target for inflammatory osteolysis
Shi Wei et al.
ADVANCES IN ANATOMIC PATHOLOGY (2007)
Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway
Hao Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction
Gabriel Mbalaviele et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction
J Zwerina et al.
ARTHRITIS AND RHEUMATISM (2006)
DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells
M Yagi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes
B Sengupta et al.
FEBS LETTERS (2004)
Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1
M Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
RANKL-induced DC-STAMP is essential for osteoclastogenesis
T Kukita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator
N Ishida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study
N Morabito et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Down-regulation of osteoclast differentiation by daidzein via caspase 3
CM Rassi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation
SE Lee et al.
BONE (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides
T Ishikawa et al.
MOLECULAR CARCINOGENESIS (2001)
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL)
M Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
